Visfatin, glucose metabolism and vascular disease: a review of evidence
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The adipose tissue is an endocrine organ producing substances called adipocytokines that have different effects on lipid metabolism, metabolic syndrome, and cardiovascular risk. Visfatin was recently described as an adipocytokine with potentially important effects on glucose metabolism and atherosclerosis. Visfatin has been linked to several inflammatory conditions, beta cell function, and cardiovascular disease. The growing number of publications on the subject shall bring further evidence about this adipocytokine. Its findings may contribute in the identification of higher risk individuals for diabetes and cardiovascular disease with a better comprehension about the complex intercorrelation between adiposity, glucose metabolism and vascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin
Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., Matsuki, Y., Murakami, M., Ichisaka, T., Murakami, H., et al. (2005) · Science · doi:10.1126/science.1097243 · Cited by 1,906
RetractedFukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., Matsuki, Y., Murakami, M., Ichisaka, T., Murakami, H., et al. (2007) · Science · doi:10.1126/science.318.5850.565b · Cited by 150
RetractedNampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme
Revollo, J. R., Körner, A., Mills, K. F., Satoh, A., Wang, T., Garten, A., Dasgupta, B., Sasaki, Y., Wolberger, C., Townsend, R. R., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.09.003 · Cited by 911 · cited 5×
“Atherosclerosis Increased serum levels [10,31] Increased expression in instable plaques [31]”
BackgroundInfluentialThe release of the adipocytokine visfatin is regulated by glucose and insulin
Haider, D. G., Schaller, G., Kapiotis, S., Maier, C., Luger, A., & Wolzt, M. (2006) · Diabetologia · doi:10.1007/s00125-006-0303-7 · Cited by 258 · cited 2×
“This effect is suppressed by insulin or somatostatin infusion [24].”
Background
Cited by
Adipose tissue in control of metabolism
Luo, L., & Liu, M. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0211 · Cited by 693
The role of adipokines in inflammatory mechanisms of obesity
Kirichenko, T. V., Markina, Y. V., Bogatyreva, A. I., Tolstik, T. V., Varaeva, Y. R., & Starodubova, A. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314982 · Cited by 289
The pathophysiology of abdominal adipose tissue depots in health and disease
Walker, G. E., Marzullo, P., Ricotti, R., Bona, G., & Prodam, F. (2014) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2014-0023 · Cited by 90
Martos-Moreno, G. Á., Kratzsch, J., Körner, A., Barrios, V, Hawkins, F., Kiess, W., & Argente, J. (2011) · International Journal of Obesity · doi:10.1038/ijo.2010.280 · Cited by 58
Ghaffari, M. A., Mousavinejad, E., Riahi, F., Mousavinejad, M., & Afsharmanesh, M. R. (2016) · Neurology Research International · doi:10.1155/2016/9060751 · Cited by 49
“Several studies revealed increases in TNF-α, resistin, and visfatin levels in various disorders such as cholelithiasis [39], diabetes, and atherosclerosis [40].”
Background
Metadata
- Authors
- Saddi-Rosa, P., Oliveira, C. S., Giuffrida, F. M., & Reis, A. F.
- Venue
- Diabetology & Metabolic Syndrome
- Published
- 2010-03-26
- Volume
- 2
- Issue
- 1
- Pages
- 21-21
- ISSN
- 1758-5996 (ISSN-L)
- OpenAlex
- W2167605063
- Cited by
- 164
- References
- 4
- FWCI
- 8.39
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Visfatin, glucose metabolism and vascular disease: a review of evidence. https://app.cochat.ai/papers/10.1186/1758-5996-2-21
- The paper
- Saddi-Rosa, P., Oliveira, C. S., Giuffrida, F. M., & Reis, A. F. (2010). Visfatin, glucose metabolism and vascular disease: a review of evidence. Diabetology & Metabolic Syndrome. https://doi.org/10.1186/1758-5996-2-21
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.